Source: Annual Congress 2012 - Treating childhood asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Zhang, S. Prietsch, A.P. Mendes, A. Groll, G. Rocha, L. Carrion, P. Silva (Rio Grande, Brazil). Inhaled corticosteroids and risk of oropharyngeal colonization by streptococcus pneumoniae in children with asthma. Eur Respir J 2012; 40: Suppl. 56, 3279

Member's Comments

No comment yet.

Related content which might interest you: Inhaled colistin in elderly patients with bronchiectasis and chronic bronchial infection with pseudomonas Source: Annual Congress 2012 - Management of severe respiratory infections Year: 2012 Treatment of patients with bronchial asthma and latent chlamydophila pneumoniae and mycoplasma pneumoniae infections by a doxycycline Source: Eur Respir J 2002; 20: Suppl. 38, 159s Year: 2002 Corticosteroid therapy combined with antibiotics for severe Streptococcus pneumoniae pneumonia in ventilated piglets Source: International Congress 2019 – Clinical challenges in respiratory infection Year: 2019 Nasopharyngeal carriage of Streptococcus pneumoniae by children with underlying pulmonary diseases Source: Eur Respir J 2005; 26: Suppl. 49, 167s Year: 2005 Inhaled drugs as risk factors for community-acquired pneumonia Source: Annual Congress 2010 - The spectrum of lower respiratory tract infections: risk factors of poor outcome and diagnostic tools Year: 2010 Mycoplasma pneumoniae infection of airways in patients with exacerbations of bronchial asthma Source: Eur Respir J 2006; 28: Suppl. 50, 237s Year: 2006 Inhaled antibiotics in chronic airway infections Source: Eur Respir Monogr 2017; 75: 57-79 Year: 2017 Chlamydia pneumoniae infection in patients with bronchial asthma Source: Eur Respir J 2004; 24: Suppl. 48, 52s Year: 2004 Infection with mycoplasma pneumoniae and chlamydia pneumoniae in non-allergic late-onset asthma Source: Eur Respir J 2006; 28: Suppl. 50, 376s Year: 2006 Chlamydia pneumoniae infection and severe asthma exacerbations Source: Eur Respir J 2002; 20: Suppl. 38, 221s Year: 2002 Inhaled drugs as risk factors for community-acquired pneumonia Source: Eur Respir J 2010; 36: 1080-1087 Year: 2010 Levofloxacin non-susceptible streptococcus pneumoniae in community-acquired respiratory infection; prevalence and risk factors Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia Year: 2007 Role of inhaled corticosteroids on recurrent bronchial infection by potentially pathogenic bacteria in patients with COPD Source: Virtual Congress 2020 – COPD : inhaled corticosteroids, bronchodilators and eosinophils Year: 2020 Antibiotics and new guidelines for the treatment of lower respiratory tract infections Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=175 Year: 2004 A study of the prevalence of streptococcus pneumoniae serotypes in patients hospitalised for community-acquired pneumonia Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues Year: 2016 Inhaled corticosteroids and the increased risk of non-tuberculous mycobacteria infection Source: International Congress 2019 – Exploring the link between inhaled corticosteroids and respiratory infection Year: 2019 Inhaled corticosteroid use and its association with Pseudomonas aeruginosa infection in COPD Source: Virtual Congress 2021 – Inhaled treatments for COPD: clinical trials and real-world studies Year: 2021 The risk of mycobacterial infections associated with inhaled corticosteroid use Source: Eur Respir J, 50 (3) 1700037; 10.1183/13993003.00037-2017 Year: 2017 Chlamydophila pneumoniae and mycoplasma pneumoniae infection of airways and exacerbations of bronchoobstructive diseases Source: Annual Congress 2008 - Lower respiratory tract infection: from outbreak to prognostic tests Year: 2008 Risk factors for MRSA staphylococcal carriage in children with chronic allergic diseases Source: Eur Respir J 2006; 28: Suppl. 50, 265s Year: 2006